Skip to main content
Back
PRME logo

Prime Medicine, Inc.

Data quality: 100%
PRME
NASDAQ Healthcare Biotechnology
$3.63
▲ $0.11 (3.13%)
Mkt Cap: 655.40M
Day Range
$3.58 $3.75
52-Week Range
$1.11 $6.94
Volume
2,252,198
50D / 200D Avg
$3.86 / $3.93
Prev Close
$3.52

Quick Summary

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (627 peers)

Metric Stock Sector Median
P/E -3.3 0.3
P/B 5.4 3.0
ROE % -146.8 3.7
Net Margin % -4342.4 3.8
Rev Growth 5Y % — 10.0
D/E 1.0 0.2

Analyst Price Target

Hold
$17.25 +375.2%
Low: $12.00 High: $23.00
Forward EPS
-$0.91
Est. Revenue
22.17M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2030 -$0.78
-$2.06 – -$0.07
 60.30M 6
FY2029 -$0.88
-$2.33 – -$0.08
 18.66M 6
FY2028 -$0.79
-$1.10 – -$0.59
 48.40M 8

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-03-03 -$0.25 -$0.22 +12.5%
2025-11-07 -$0.28 -$0.32 -14.3%
2025-08-07 -$0.36 -$0.41 -13.9%
2025-05-08 -$0.32 -$0.40 -25.0%
2025-02-28 -$0.37 -$0.31 +16.2%
2024-11-12 -$0.43 -$0.44 -2.3%
2024-08-08 -$0.40 -$0.46 -15.0%
2024-05-10 -$0.45 -$0.44 +2.2%

Dividend History

1 yr streak

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

Ex-Date Payment Date Amount Yield
Sep 10, 2019 Sep 12, 2019 $0.80 7.89%
Jun 14, 2019 Jun 28, 2019 $0.20 4.20%
Dec 18, 2018 Dec 31, 2018 $0.21 3.89%
Sep 14, 2018 Sep 28, 2018 $0.23 8.11%
Jun 21, 2018 Jun 29, 2018 $0.15 7.02%
Mar 22, 2018 Mar 29, 2018 $0.01 6.80%
Dec 21, 2017 Dec 29, 2017 $0.86 6.96%
Sep 21, 2017 Sep 29, 2017 $0.07 6.08%
Jun 22, 2017 Jun 30, 2017 $0.11 6.69%
Mar 23, 2017 Mar 31, 2017 $0.03 7.05%
Dec 21, 2016 Dec 30, 2016 $0.73 6.98%
Sep 21, 2016 Sep 30, 2016 $0.17 2.84%
Jun 22, 2016 Jun 30, 2016 $0.17 1.80%
Mar 23, 2016 Mar 31, 2016 $0.02 0.72%
Dec 23, 2015 Dec 31, 2015 $0.09 0.59%

Key Takeaways

Negative free cash flow of -167.10M
PEG of 0.14 suggests growth is underpriced
Capital intensive — 97.82% of revenue goes to capex

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)55.28%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-146.81%
ROIC-65.85%
Net Margin-4342.44%
Op. Margin-4498.06%

Safety

Debt / Equity
0.96
Current Ratio4.84
Interest Coverage0.00

Valuation

P/E Ratio
-3.26
Forward P/EN/A
P/B Ratio5.42
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 55.28% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4.63M Net Income (TTM) -201.14M
ROE -146.81% ROA -58.69%
Gross Margin -58.05% Operating Margin -4498.06%
Net Margin -4342.44% Free Cash Flow (TTM) -167.10M
ROIC -65.85% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.96 Current Ratio 4.84
Interest Coverage 0.00
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years 1 yrs
Valuation
P/E Ratio -3.26 Forward P/E N/A
P/B Ratio 5.42 P/S Ratio 141.49
PEG Ratio 0.14 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA 159.84
Forward P/S 29.56 Fwd Earnings Yield N/A
FCF Yield -25.49%
Market Cap 655.40M Enterprise Value 708.80M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 4.63M 2.98M 0.0 0.0 0.0
Net Income -201.14M -195.88M -198.13M -121.82M -165.37M
EPS (Diluted) -1.35 -1.65 -2.18 -1.46 -1.92
Gross Profit -2.69M 2.98M 0.0 0.0 0.0
Operating Income -208.35M -202.47M -204.79M -116.54M -84.47M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 342.73M 297.51M 193.85M 360.31M 301.86M
Total Liabilities 221.87M 144.36M 60.78M 44.04M 62.30M
Shareholders' Equity 120.87M 153.15M 133.07M 316.27M 239.56M
Total Debt 116.43M 40.79M 13.63M 28.75M 10.41M
Cash & Equivalents 63.03M 182.48M 41.57M 187.62M 185.42M
Current Assets 181.29M 211.89M 142.98M 296.62M 270.58M
Current Liabilities 37.45M 37.96M 56.42M 26.71M 57.98M